Melanotan I

Melanotan I (Afamelanotide) is a laboratory-produced peptide that mimics the effects of the naturally occurring alpha-melanocyte stimulating hormone (α-MSH). By binding to melanocortin receptors, Melanotan I promotes increased melanin synthesis, which may lead to darker skin pigmentation and enhanced protection against UV-induced skin damage.

In research settings, Melanotan I has been studied for its potential applications in pigmentation disorders, photosensitivity conditions, and skin protection. Unlike Melanotan II, Melanotan I is more selective in its receptor activity and is generally associated with fewer off-target effects.

Researchers value Melanotan I for its stability, consistent activity, and ability to produce gradual pigmentation changes when administered according to research protocols. This peptide is intended strictly for laboratory and scientific research purposes and is not intended for human consumption unless approved by relevant regulatory authorities.